Company Overview and News
Stocks were flat in the early morning hours on Thursday, but futures turned higher on all three major U.S. equity indexes. The markets are back to challenging their highs as well, but not necessarily in international and emerging markets. As many investors have seen lower upside from buying on market pullbacks than in prior years, they have to consider how they want to have their investments positioned for the rest of 2018 and as 2019 approaches.
VIA CATR CAT AMD NVDA RHT DO ARGX TRI MS RIG BRKR
begin 644 filename1.pdf M)5!$1BTQ+C4-)>+CS],-"[email protected],"!O8FH-/#PO3&EN96%R:7IE9" [email protected],S,U M.3DO3R Q,2]%(#(X,[email protected],B]4(#,S,S [email protected]@6R [email protected],30Y73X^#65N M9&]B:@[email protected](" @(" @(" @(" @(" @(" @#0HQ-B P(&]B:@T\/"]$96-O9&50 M87)M7!E+UA2968O5ULQ(#(@,5T^/G-T('$UVX&)D:&&2 E#(Q,_QEW_P<(, "0\@[email protected] M#0IE;F1S=')E86T-96YD;V)J#7-T87)T>')[email protected]*, T*)25%3T8-"B @(" @ M(" @#0HQ.2 P(&]B:@T\/"]&:6QT97(O1FQA=&5$96-O9&4O22 X,R],96YG [email protected]@-S O4R T.
begin 644 filename1.pdf M)5!$1BTQ+C4-)>+CS],-"[email protected],"!O8FH-/#PO3&EN96%R:7IE9" [email protected],S,R M.34O3R Q,2]%(#(X,[email protected],B]4(#,[email protected]@6R [email protected],30Y73X^#65N M9&]B:@[email protected](" @(" @(" @(" @(" @(" @#0HQ-B P(&]B:@T\/"]$96-O9&50 M87)M7!E+UA2968O5ULQ(#(@,5T^/G-T
Viacom (NASDAQ:VIA,VIAB) unquestionably is cheap. The B shares of Viacom stock trade at barely seven times 2018 consensus EPS estimates. VIAB stock also has an attractive 2.76% dividend yield.
CBS VIA AMZN AMCX CBS.A NFLX CPV CBS.WD BEAV
Investors eyeing the ongoing transformation of the telecom-media-technology (TMT) landscape are likely gearing up for Goldman Sachs’ annual Communacopia Conference later this week.
VIA AMZN VOD TWX NFLX TWC FOXA DIS
(Reuters) - CBS Corp (CBS.N) said on Monday it will pay $120 million to former Chief Executive Officer Leslie Moonves if an internal investigation into allegations of harassment fails to provide grounds for his dismissal.
CBS VIA CBS.A VIAB CPV CBS.WD
B. Riley analyst Barton Crockett wrote Monday that the departure of CBS Corp. CBS, -3.59% Chief Executive Les Moonves amid sexual-harassment allegations was "quickly easing uncertainties" around the stock and would "lessen near-term angst." He argued that the company will be able to survive without Moonves at the helm, as other TV-network groups have been able to continue "strong performance" following the resignations of "vaunted, tainted" stars.
CBS VIA CBS.A VIAB VZ CPV CBS.WD VZA
Monday, September 10, 2018 To kick off a new week in the U.S. indexes we see a few inter-weaving themes: CEOs stepping down (for different reasons) and expectations from Apple Inc. (AAPL - Free Report) as well as its suppliers. Les Moonves is exiting CBS Corp. (CBS - Free Report) , the company he’d run for more than 20 years, while Alibaba (BABA - Free Report) -co-founder Jack Ma gives himself exactly one more year at the helm of the firm.
VIA CBS CBS.A AAPL CPV CBS.WD
2018-09-18 - Asif
Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...
2018-09-18 - Asif
Overview The company design, develop and sell exoskeleton technology to augment human strength, endurance and mobility. The company's exoskeleton technology serves multiple markets and can be used both by able-bodied users as well as by persons with physical disabilities. Ekso Bionics has sold, rented or leased devices that (a) enable individuals with neurological conditions affecting gait (stroke and spinal cord injury) to rehabilitate and to walk again and (b) allow industrial workers to perform heavy duty work for extended periods. Today, its medical exoskeleton, Ekso GT, is used as a rehabilitation tool to allow physicians and therapists to rehabilitate patients who have suffered a stroke or spinal cord injury. With its unique features designed specifically for hospitals and its proprietary SmartAssist software, Ekso GT allows for the early mobilization of patients, with high step count and high dosage treatments. The intent is to allow the patient’s central nervous syst...
2018-09-18 - Asif
Overview Agile Therapeutics is a forward-thinking women’s healthcare company dedicated to fulfilling the unmet health needs of today’s women. Twirla® and its other current potential product candidates are designed to provide women with contraceptive options that offer greater convenience and facilitate compliance. The company's lead product candidate, Twirla, also known as AG200-15, is a once-weekly prescription contraceptive patch that is at the end of Phase 3 clinical development. Since its inception in 1997, Agile Therapeutics has devoted substantial resources to developing Twirla, building its intellectual property portfolio, business planning, raising capital and providing general and administrative support for these operations. The company incurred research and development expenses of $14.4 million, $20.9 million and $25.6 million during the years ended December 31, 2017, 2016 and 2015, respectively. The company incurred research and development expenses of $2.4 milli...
Silicon Investor Message Boards
This table lists all message boards related to VIA / Viacom, Inc. on message board site Silicon Investor.
as of ET